Identification of Novel Non-nucleoside Reverse Transcriptase Inhibitors Using Fragment-based Lead Generation

By Ramajayam R.   Giridhar Rajani   Yadav M.   De Clercq Erick   Pannecouque Christophe   Prajapati Dhaval  

Medicinal Chemistry Research, Vol. 14, Iss. 8-9, 2005-12 ,pp. : 475-487

Springer Publishing Company

Access to resources Recommend Favorite

Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 2, 2014-06 ,pp. : 115-123

Bentham Science Publishers

Access to resources Recommend Favorite

JTK-853, a Novel Non-Nucleoside Hepatitis C Virus Polymerase Inhibitor, Demonstrates a High Genetic Barrier to Resistance in vitro

By  

Intervirology, Vol. 56, Iss. 5, 2013-07 ,pp. : 302-309

Karger

Access to resources Recommend Favorite

GSK2878175, a pan‐genotypic non‐nucleoside NS5B polymerase inhibitor, in healthy and treatment‐naïve chronic hepatitis C subjects

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 1, 2018-01 ,pp. : 19-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

Challenges in HIV‐persistent viral replication regardless of potent antiretroviral therapy

By  

ORAL DISEASES, Vol. 22, Iss. 7, 2016-10 ,pp. : 585-586

John Wiley & Sons Inc

Access to resources Recommend Favorite